Source: BioPortfolio

Neuravi: Cerenovus treats first ischemic stroke patients with Embotrap II revascularization device

The first patients have been treated with the Embotrap II which is a next generation stent retriever used to capture and remove lifethreatening blood clots from the brain The post Cerenovus treats first ischemic stroke patients with Embotrap II revasculari...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Eamon Brady's photo - Co-Founder & CEO of Neuravi

Co-Founder & CEO

Eamon Brady

CEO Approval Rating

69/100

Read more